A61K 40/405
Invertebrates antigens
Official title: {Invertebrates antigens}
A61K40/405 (Invertebrates antigens) appears on 1 US grants and 13 published applications in this corpus.
Search patents in A61K- Granted patents
- 1
- Published applications
- 13
- Assignees
- 9
- Inventors
- 36
- Latest grant
- 25 Jan 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- In vivo and ex vivo production of car-neutrophils and use thereof to treat and image cancer23 Jul 2026US 2026/0207776 A1Purdue Research Foundation
- Amino lipid compound, preparation method therefor, and use thereof15 Jan 2026US 2026/0015311 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- IPSC-Based Gamma-Delta T-Cells, Compositions and Methods of Use Thereof27 Mar 2025US 2025/0099585 A1IN8bio, Inc.
- Chlorotoxin derivatives and use thereof11 Apr 2024US 2024/0115717 A1Vrg Therapeutics Kft.
- Dual-targeting chimeric antigen receptor modified t cells comprising il-13 and chlorotoxin for cancer treatment23 Nov 2023US 2023/0374085 A1City of Hope
Most cited
By later US patents